Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.

Prof. Salwa Hindawi is a Consultant in Hematology and Transfusion Medicine and serves as part time consultant with MOH, President and Scientific Officer of the Saudi Society of Transfusion Medicine & Services, Jeddah. She is also President of the Saudi Friends for Thalassemia & Sickle Cell Anemia Society. Dr. Hindawi holds key roles in ISBT, WHO, AABB, CAP, and as member of Editorial board of Vox Sanguinis, contributing globally to blood safety, PBM, hemovigilance, and transfusion medicine standards.